Four things to know:
1. The annual MedTech list honors companies that tackle surgical challenges in orthopedics.
2. Biologica’s main product, ProteiOS growth factor, is a soluble protein compound derived from the endosteum of allograft bone.
3. ProteiOS consists of a collection of growth factors, oxygenating peptides, collagen deposition peptides and cellular attachment peptides.
4. The product was initially launched for the orthopedic and neurosurgery markets.
More articles on biologics:
Dr. Adrian Park: Work-related injuries affecting orthopedic, spine surgeons & other specialists
Penn Medicine researchers seek to improve spinal discs’ early response to injury
Emory, Duke & more: 4 facilities participate in $13M clinical trial for knee stem cell treatment
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
